 | Up a level |
Schüpbach, Jörg; Gebhardt, Martin D; Tomasik, Zuzana; Niederhauser, Christoph; Yerly, Sabine; Bürgisser, Philippe; Matter, Lukas; Gorgievski, Meri; Dubs, Rolf; Schultze, Detlev; Steffen, Ingrid; Andreutti, Corinne; Martinetti, Gladys; Güntert, Bruno; Staub, Roger; Daneel, Synove; Vernazza, Pietro (2007). Assessment of recent HIV-1 infection by a line immunoassay for HIV-1/2 confirmation. PLoS medicine, 4(12), e343. San Francisco, Calif.: Public Library of Science 10.1371/journal.pmed.0040343
Schaad, Heinz J.; Malinverni, Raffaele; Campbell, Lee Ann; Matter, Lukas (1999). Myocardial Infarction, Culture-Negative Endocarditis, and Chlamydia pneumoniae Infection: A Dilemma? Clinical infectious diseases, 28(1), pp. 162-163. The University of Chicago Press 10.1086/517195
Matter, Lukas; Kogelschatz, Karen; Germann, Daniel (1997). Serum Levels of Rubella Virus Antibodies Indicating Immunity: Response to Vaccination of Subjects with Low or Undetectable Antibody Concentrations. Journal of infectious diseases, 175(4), pp. 749-755. The University of Chicago Press 10.1086/513967
Jönsson, Bengt; Horisberger, Bruno; Bruguera, Miguel; Matter, Lukas (1991). Cost-Benefit Analysis of Hepatitis-B Vaccination: A Computerized Decision Model for Spain. International journal of technology assessment in health care, 7(3), pp. 379-402. Cambridge University Press 10.1017/S0266462300005754
